Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial
Brain Stimulation · 2025
DOI: 10.1016/j.brs.2025.08.018 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Brain Stimulation, 2025. Verfasst von Kallene Summer Vidal und 17 weiteren Autor:innen. Beteiligte Einrichtung: Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation, COVID-19, Cognitive Behavioral Therapy, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Post-acute sequelae of SARS-CoV-2 infection (PASC) is characterized by persistent cognitive deficits alongside anxiety and depression symptoms that adversely affect quality of life. Cognitive training (CT) programs and non-invasive neuromodulation, specifically transcranial direct current stimulation (tDCS), have each shown promise for alleviating similar deficits in non-clinical populations. However, their combined efficacy has not yet been evaluated in PASC patients. Therefore, this study aimed to determine whether the combination of CT and tDCS produces benefits for cognitive and mood-related symptoms in individuals with PASC. METHODS: We conducted a double-blind, randomized, sham-controlled clinical trial in adults aged 18-75 with confirmed SARS-CoV-2 infection within the past six months and persisting cognitive complaints. They were randomized to a 4-week in-person intervention of 20 weekday sessions of either active (2 mA anodal-left, cathodal-right prefrontal stimulation) or sham tDCS paired with an app-based CT program. Primary outcomes were six standardized neuropsychological tests assessing verbal memory, working memory, executive functioning, attention, and language, administered at baseline and immediately post-intervention. As secondary outcomes, we assessed changes in depression and anxiety symptoms over the treatment period. RESULTS: Sixty participants (mean age 43.8 ± 13.2 years, 71.7 % women) were randomized to active tDCS + CT or sham tDCS + CT groups, and 52 finished the trial. Compared to sham, tDCS + CT resulted in significantly greater improvement in tests evaluating inhibitory control (effect size [ES] = 0.07, 95 % CI 0 to 0.23, p = 0.046), processing speed (ES = 0.08, 95 % CI 0 to 0.25, p = 0.034), and divided attention (ES = 0.08, 95 % CI 0 to 0.24, p = 0.039), but not in tests evaluating other domains. Both groups improved similarly in depression and anxiety symptoms. Participant's and rater's active guess rates did not differ between groups (ps > 0.20). CONCLUSION: An intervention with prefrontal targeted tDCS + CT in patients with PASC with cognitive complaints might be effective in improving attention, processing speed and inhibitory control, although further studies are warranted to prospectively confirm these findings. CLINICALTRIALS: GOV: NCT05389592.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilians Universität, Nussbaumstraße 7, 80336 Munich, Germany; DZPG (German Center for Mental Health), Partner Site Augsburg, Munich-Germany; Charlotte Fresenius Hoc…
- Division of Geriatrics, University of Sao Paulo Medical School, São Paulo, Brazil.
- Department of Head and Skin, Psychiatry and Medical Psychology, Ghent University Hospital, Ghent University, Ghent, Belgium; Ghent Experimental Psychiatry Laboratory, Ghent University, Ghent, Belgium.
- Department of Biomedical Engineering. The City College of New York, New York, NY USA 10031.
- Department of Neurology, NYU Grossman School of Medicine, New York, NY USA 10017.
Zitieren
APA
Vidal, K. S., Cavendish, B. A., Goerigk, S., Pita Batista, M., Oliveira Lima, A. R., Pinto, B. S., Neto Domingos, A. A., de Sousa, J. P., Pelosof, R., Bertola, L., Silva, V., Suemoto, C. K., Razza, L. B., Bikson, M., Pilloni, G., Charvet, L., Silva, P. H. R., & Brunoni, A. R. (2025). Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial. Brain Stimulation. https://doi.org/10.1016/j.brs.2025.08.018
Vancouver
Vidal KS, Cavendish BA, Goerigk S, Pita Batista M, Oliveira Lima AR, Pinto BS, et al. Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial. Brain Stimulation. 2025. doi:10.1016/j.brs.2025.08.018
BibTeX
@article{Vidal2025,
author = {Vidal, Kallene Summer and Cavendish, Beatriz Araújo and Goerigk, Stephan and Pita Batista, Mariana and Oliveira Lima, Alisson Rafael and Pinto, Bianca Silva and Neto Domingos, Adriano Augusto and de Sousa, Juliana Pereira and Pelosof, Rebeca and Bertola, Laiss and Silva, Valquiria and Suemoto, Claudia Kimie and Razza, Lais Boralli and Bikson, Marom and Pilloni, Giuseppina and Charvet, Leigh and Silva, Pedro H R and Brunoni, Andre R},
title = {Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial},
journal = {Brain Stimulation},
year = {2025},
doi = {10.1016/j.brs.2025.08.018}
}
EUVIMED